Terms: = Leukemia AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2
500 results:
1. GDF11 level and its effect on prognosis in patients with acute myeloid leukemia.
Aslan NA; Avcı E; Şenol H; Güler N
J Investig Med; 2024 Apr; 72(4):341-348. PubMed ID: 38415361
[TBL] [Abstract] [Full Text] [Related]
2. Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia.
Polat MC; Sönmez Ç; Yarali N; Özbek NY
Eur J Pediatr; 2024 May; 183(5):2155-2162. PubMed ID: 38367066
[TBL] [Abstract] [Full Text] [Related]
3. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt.
Sedeta E; Jemal A; Nisotel L; Sung H
Cancer; 2024 Jun; 130(11):1952-1963. PubMed ID: 38244208
[TBL] [Abstract] [Full Text] [Related]
4. Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update.
Roskoski R
Pharmacol Res; 2024 Feb; 200():107059. PubMed ID: 38216005
[TBL] [Abstract] [Full Text] [Related]
5. Quality and Quantity of Nucleic Acids Extracted from Formalin-Fixed Paraffin-Embedded Lymphoma Biopsies from Nigerian Archived Biopsy.
Uzoma IC; Taiwo IA; Ugwu NI; Durosinmi MA; Akinloye O
Niger J Clin Pract; 2023 Dec; 26(12):1854-1860. PubMed ID: 38158353
[TBL] [Abstract] [Full Text] [Related]
6. Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage erbb2/her2-Positive Breast Cancer.
Zagami P; Fernandez-Martinez A; Rashid NU; Hoadley KA; Spears PA; Curigliano G; Perou CM; Carey LA
JAMA Netw Open; 2023 Dec; 6(12):e2348814. PubMed ID: 38117494
[TBL] [Abstract] [Full Text] [Related]
7. Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy.
Hu R; Ling X; Yang T; Zhang J; Gu X; Li F; Chen H; Wen Y; Li Z; Zou Y; Du Y
Clin Exp Med; 2023 Dec; 23(8):4623-4632. PubMed ID: 37925379
[TBL] [Abstract] [Full Text] [Related]
8. Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival.
Lipsyc-Sharf M; Ballman KV; Campbell JD; Muss HB; Perez EA; Shulman LN; Carey LA; Partridge AH; Warner ET
JAMA Netw Open; 2023 Oct; 6(10):e2339584. PubMed ID: 37878313
[TBL] [Abstract] [Full Text] [Related]
9. AXL - a new player in resistance to her2 blockade.
Adam-Artigues A; Arenas EJ; Arribas J; Prat A; Cejalvo JM
Cancer Treat Rev; 2023 Dec; 121():102639. PubMed ID: 37864955
[TBL] [Abstract] [Full Text] [Related]
10. [A comparative study of the effects of citrate and heparin anticoagulation on coagulation function and efficacy in children with septic shock undergoing continuous blood purification].
Zhong X; Luo S; Ren R; Lai J; Deng G; Zhu H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):856-859. PubMed ID: 37593866
[TBL] [Abstract] [Full Text] [Related]
11. Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy.
Dong S; Matossian MD; Yousefi H; Khosla M; Collins-Burow BM; Burow ME; Alahari SK
Sci Rep; 2023 Jul; 13(1):11843. PubMed ID: 37481672
[TBL] [Abstract] [Full Text] [Related]
12. Mediators of Black-White inequities in cardiovascular mortality among survivors of 18 cancers in the USA.
Sung H; Hyun N; Ohman RE; Yang EH; Siegel RL; Jemal A
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 37471575
[TBL] [Abstract] [Full Text] [Related]
13. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management.
Shyam Sunder S; Sharma UC; Pokharel S
Signal Transduct Target Ther; 2023 Jul; 8(1):262. PubMed ID: 37414756
[TBL] [Abstract] [Full Text] [Related]
14. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of Erb-B2 Receptor Tyrosine Kinase 3 and Associated Regulatory Pathways Potently Impairs Malignant Peripheral Nerve Sheath Tumor Proliferation and Survival.
Black LE; Longo JF; Anderson JC; Carroll SL
Am J Pathol; 2023 Sep; 193(9):1298-1318. PubMed ID: 37328102
[TBL] [Abstract] [Full Text] [Related]
16. Evaluating the Activity of neuraminidase in Bacterial Vaginosis Microflora and Imaging Sialic Acid on the Cell Membrane by Boron and Nitrogen Codoped Fluorescent Carbon Dots.
Liu X; Zhang Y; Yu W; Zhang W; Jiang J; Gu Q; Wang X; Wu Y
ACS Sens; 2023 Jul; 8(7):2556-2562. PubMed ID: 37322599
[TBL] [Abstract] [Full Text] [Related]
17. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Liu S; Xie SM; Liu W; Gagea M; Hanker AB; Nguyen N; Singareeka Raghavendra A; Yang-Kolodji G; Chu F; Neelapu SS; Marchese A; Hanash S; Zimmermann J; Arteaga CL; Tripathy D
Breast Cancer Res; 2023 Jun; 25(1):62. PubMed ID: 37280713
[TBL] [Abstract] [Full Text] [Related]
18. Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function.
Renauer P; Park JJ; Bai M; Acosta A; Lee WH; Lin GH; Zhang Y; Dai X; Wang G; Errami Y; Wu T; Clark P; Ye L; Yang Q; Chen S
Cancer Immunol Res; 2023 Aug; 11(8):1068-1084. PubMed ID: 37253111
[TBL] [Abstract] [Full Text] [Related]
19. Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid leukemia Based on Integrating Network Pharmacology and Molecular Docking.
Li HX; Jing YX; Chai YH; Sun XH; He XX; Xue SL; Xi YM; Ma XL
Anticancer Agents Med Chem; 2023; 23(16):1838-1847. PubMed ID: 37246327
[TBL] [Abstract] [Full Text] [Related]
20. CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest.
Cao W; Yao S; Li A; Chen H; Zhang E; Cao L; Zhang J; Hou Y; Dai Z; Chen J; Huang X; Yang L; Cai Z
J Zhejiang Univ Sci B; 2023 May; 24(5):442-454. PubMed ID: 37190893
[TBL] [Abstract] [Full Text] [Related]
[Next]
